Clinical Trial Update: Efficacy, Safety, & Pharmacokinetics of Candesartan Cilexetil in Hypertensive Paediatric Subjects 6 to < 17 Years of Age [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update assessing the efficacy, safety, and pharmacokinetics of candesartan cilexetil in hypertensive paediatric subjects aged 6 to <17 ye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• candesartan cilexetil (candesartan cilexetil)

Snippet

Sponsor: AstraZeneca | Conditions: Hypertension | Phase 3 | Status: COMPLETED